Larvol Delta - Cogent-Biosciences-Announces-FDA-Acceptance-of-New-Drug-Application-NDA-with-Priority-Review-for-Bezuclastinib-in-Combination-with-Sunitinib-for-Patients-with-GIST

bezuclastinib (PLX9486) - Cogent Biosci

https://www.globenewswire.com/news-release/2026/05/28/3302753/0/en/cogent-biosciences-announces-fda-acceptance-of-new-drug-application-nda-with-priority-review-for-bezuclastinib-in-combination-with-sunitinib-for-patients-with-gist.html

May 28, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next